Notifications
Clear all
Topic starter
16/12/2019 5:55 pm
Hi, I am currently taking 1000mg test a week (enanthate) and making very good gains. I have been using for approx 10 years now, so I have some experience when it comes to anabolics, but not so much when it comes to EPO. I am getting ready for a show(bodybuilding) at the moment and want to see how much ARANESP I would need to use to get a visual improvement in vascularity. I am 5' 10'' 200lbs and under 8%bf. I have 2 types of Aranesp sureclick pens, one is 60mcg and the other 40mcg, I have 24 pens in total, could someone please help me on a dosage shedule for administration. Many many thanks if your able to help.
P.S. Would there be a BIG change in vascularity ?
16/12/2019 6:11 pm
first things first....whats your Hct%? There are many ways to increase vascularity....EPO is not the first one I'd choose for this purpose.
Then again i'm not a BBer... and you guys are crazy with shit. You guys would eat fermented elephant nuts if it promised another lb of LBM. I apologize if you're the exception.
That being said if you want to send that Nesp to someone who could really use it PM me.
MS, CSCS, CPT
16/12/2019 6:29 pm
I do know WASP(darpotein alpha) protocol for endurance not for BB tho.Are u tested?WASP can stay in system for a couple of months ;works quicker than epotein alpha (E) and is more effective.It was very popular in Belgium a few years ago. M/track
16/12/2019 6:54 pm
Mad the Wasp can stay in systems for months if you inyected s.c no? If you inyected i.v option i think is imposible is detected(In urine) 1 months after the last iny... In blond i think is easy detected...There are much studys to respect:
http://66.102.9.104/search?q=cache:...clnk&cd;=1≷=es
DISCUSSIONDarbepoetin- was detected in all blood samples taken 2–14 days after intra-venous or subcutaneous injections by the higher increase in immunoactivity afterneuraminidase treatment. In the present study the blood samples with darbepoetin-were from patients with kidney disease and not from athletes which would be the case if the method is used for doping control. If the kidneys play an important rolefor the degradation of darbepoetin- , it could be expected that in these patients withkidney disease, an accumulation of the drug in serum may occur after long treat-ment. However, pharmacokinetic studies have not given any evidence for such anaccumulation in patients with renal failure given darbepoetin- intravenously orsubcutaneously once weekly (10). The metabolic fate of circulating native EPO,rHuEPO and darbepoetin- is still an enigma. Jelkman (11) concluded in a reviewthat the liver and the kidneys do not seem to play a major role in the degradationand that the majority of EPO and its analogues most likely are degraded followingEPO-receptor-mediated uptake in the bone marrow. The pharmacokinetic profile ofdarbepoetin- in patients with cancer was reported to be similar to that in patientswith chronic kidney disease (12).
16/12/2019 7:12 pm
I dont know anyone who has used Wasp Sq only IV the detection time for IV would be less than SQ;but do not know definitive figures . Interesting study;but does not state catergoricaly testing status of Wasp in any atheletes.when used Wasp IV.M/track